It has been brought to our attention that this article from the June 2014 issue of the European Respiratory Journal was originally published with an error in reporting the association of peripheral arterial disease (PAD) duration with major adverse cardiovascular and cerebrovascular events (MACCE), obstructive sleep apnoea (OSA), clinical coronary artery disease and decreased high-density lipoprotein (HDL) to total cholesterol ratio.
It was originally reported that a PAD duration of ≥4 years was associated with MACCE, along with OSA, clinical coronary artery disease and decreased HDL/total cholesterol ratio.
This was due to the misinterpretation of the statistician's report regarding the effect of PAD duration. In truth, the association was vice versa; a PAD duration of <4 years was predictive of adverse outcome. In other words, a rapidly developed need for surgical intervention from the onset of clinical PAD was a significant risk factor, not one with a longer …